An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“orthogonally confirmed dose-dependent KAT2A degradation by western blot, and demonstrated that this degradation can be rescued by pre-treatment with a UBA3/NAE1 inhibitor, MLN4924 (37), a proteasome inhibitor, bortezomib (38), and a competing CRBN ligand, pomalidomide (7) (Fig. 1D).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [37]
In the citing paper
“we cotreated cells with a proteasome inhibitor (bortezomib) or a NEDD8-activating enzyme E1 inhibitor (MLN-4924 32 ) and found that both inhibitors prevented degradation of BTK (Figure 2D).”
From Bruton tyrosine kinase degradation as a therapeutic strategy for cancer (2019) · cites this paper as [32]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Self-citationKobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins
Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093503 · Cited by 1,517
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Duda, D. M., Borg, L. A., Scott, D. C., Hunt, H. W., Hammel, M., & Schulman, B. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.022 · Cited by 767
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 653
Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy
Kane, R. C., Bross, P. F., Farrell, A. T., & Pazdur, R. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-508 · Cited by 628
Cited by
Items 701–800 of 1,005
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy
Zhou, L., Lin, X., Zhu, J., Zhang, L., Chen, S., Yang, H., Jia, L., & Chen, B. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01337-w · Cited by 42
Driscoll, J. J., & DeChowdhury, R. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0165-2 · Cited by 43
CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells
Jumpertz, S., Hennes, T., Asare, Y., Schütz, A. K., & Bernhagen, J. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.013 · Cited by 38
Misra, M., Kühn, M., Löbel, M., An, H., Statsyuk, A. V., Sotriffer, C., & Schindelin, H. (2017) · Structure · doi:10.1016/j.str.2017.05.001 · Cited by 38
Best, S., Lam, V., Liu, T., Bruss, N., Kittai, A. S., Danilova, O. V., Murray, S., Berger, A., Pennock, N. D., Lind, E. F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0794-0 · Cited by 39
Self-citationRapsyn as a signaling and scaffolding molecule in neuromuscular junction formation and maintenance
Xing, G., Xiong, W., & Mei, L. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135013 · Cited by 40
Meng, C., Liu, L.-K., Li, D.-L., Gao, R.-L., Fan, W.-W., Wang, K.-J., Wang, H., & Liu, H. (2020) · Journal of Virology · doi:10.1128/jvi.01570-20 · Cited by 38
Neddylation inhibitor MLN4924 has anti‐HBV activity via modulating the ERK‐HNF1α‐C/EBPα‐HNF4α axis
Xie, M., Guo, H., Lou, G., Yao, J., Liu, Y., Sun, Y., Yang, Z., & Zheng, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16137 · Cited by 40
Huang, D., Li, Q., Sun, X., Sun, X., Tang, Y., Qu, Y., Liu, D., Yu, T., Li, G., Tong, T., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00689-5 · Cited by 41
Maneiro, M., Vita, E. D., Conole, D., Kounde, C. S., Zhang, Q., & Tate, E. W. (2021) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2021.01.002 · Cited by 41
Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase
Kim, Y., Seo, P., Jeon, E., You, I., Hwang, K., Kim, N., Tse, J., Bae, J., Choi, H., Hinshaw, S. M., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.07.008 · Cited by 38
Xie, C., Wei, D., Zhao, L., Marchetto, S., Mei, L., Borg, J., & Sun, Y. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201411104 · Cited by 39
Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery
Hussain, M., Lu, Y., Liu, Y., Su, K., Zhang, J., Liu, J., & Zhou, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.027 · Cited by 40
Self-citationRadiosensitization of Human Colorectal Cancer Cells by MLN4924
Wan, J., Zhu, J. Y., Li, G., & Zhang, Z. (2015) · Technology in Cancer Research & Treatment · doi:10.1177/1533034615588197 · Cited by 38
Developmental SALL2 transcription factor: a new player in cancer
Hermosilla, V. E., Hepp, M. I., Escobar, D., Farkas, C., Riffo, E. N., Castro, A. F., & Pincheira, R. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx036 · Cited by 38
Multiple UBX proteins reduce the ubiquitin threshold of the mammalian p97-UFD1-NPL4 unfoldase
Fujisawa, R., Polo Rivera, C., & Labib, K. P. (2022) · eLife · doi:10.7554/elife.76763 · Cited by 37
Ubiquitination detection techniques
Silva, A. R. I. D., & Page, R. C. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231191186 · Cited by 39
A selective inhibitor of the UFM1-activating enzyme, UBA5.
da Silva, S. D., Paiva, S.-L., Bancerz, M., Geletu, M., Lewis, A. M., Chen, J.-J., Cai, Y.-F., Lukkarila, J. L., Li, H.-L., & Gunning, P. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.015 · Cited by 36
Roles of SAMHD1 in antiviral defense, autoimmunity and cancer
Li, M., Zhang, D., Zhu, M., Shen, Y., Wei, W., Ying, S., Körner, H., & Li, J. (2017) · Reviews in Medical Virology · doi:10.1002/rmv.1931 · Cited by 41
Cullin-3–KCTD10-mediated CEP97 degradation promotes primary cilium formation
Nagai, T., Mukoyama, S., Kagiwada, H., Goshima, N., & Mizuno, K. (2018) · Journal of Cell Science · doi:10.1242/jcs.219527 · Cited by 38
Targeting the Ubiquitin System in Glioblastoma
Scholz, N., Kurian, K. M., Siebzehnrübl, F. A., & Licchesi, J. D. F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.574011 · Cited by 37
A PROTAC targets splicing factor 3B1
Gama-Brambila, R. A., Chen, J., Zhou, J., Tascher, G., Münch, C., & Cheng, X. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.018 · Cited by 39
Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?
Liu, M., Wu, K., Lin, J., Xie, Q., Liu, Y., Huang, Y., Zeng, J., Yang, Z., Wang, Y., Dong, S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.695957 · Cited by 38
Neddylation is essential for β-catenin degradation in Wnt signaling pathway
Wang, B., Wang, T., Zhu, H., Yan, R., Li, X., Zhang, C., Tao, W., Ke, X., Hao, P., & Qu, Y. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110538 · Cited by 40
Prognostic impact of RING box protein-1 (RBX1) expression in gastric cancer
Migita, K., Takayama, T., Matsumoto, S., Wakatsuki, K., Tanaka, T., Ito, M., Nishiwada, S., & Nakajima, Y. (2013) · Gastric Cancer · doi:10.1007/s10120-013-0318-y · Cited by 37
Czuczman, N. M., Barth, M. J., Gu, J. J., Neppalli, V. T., Mavis, C. K., Frys, S., Hu, Q., Liu, S., Klener, P., Vočková, P., et al. (2015) · Blood · doi:10.1182/blood-2015-04-640920 · Cited by 37
A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1
Tutter, A., Buckley, D., Golosov, A. A., Ma, X., Shu, W., McKay, D. J. J., Darsigny, V., Dovala, D., Beckwith, R., Solomon, J., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01936-x · Cited by 36
Targeting Neddylation in Cancer Therapy
Duncan, K., Schäfer, G., Vava, A., Parker, M. I., & Zerbini, L. F. (2012) · Future Oncology · doi:10.2217/fon.12.131 · Cited by 37
Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6
Tan, Y., Ci, Y., Dai, X., Wu, F., Guo, J., Liu, D., North, B. J., Huo, J., & Zhang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.18141 · Cited by 39
Self-citationCSN6–TRIM21 axis instigates cancer stemness during tumorigenesis
Qin, B., Zou, S., Li, K., Wang, H., Wei, W., Zhang, B., Xiao, L., Choi, H. H., Tang, Q., Huang, D., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0779-9 · Cited by 36
Old and New Concepts in Ubiquitin and NEDD8 Recognition
Santonico, E. (2020) · Biomolecules · doi:10.3390/biom10040566 · Cited by 38
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma
Paradžik, T., Bandini, C., Mereu, E., Labrador, M., Taìana, E., Amodio, N., Neri, A., & Piva, R. (2021) · Cancers · doi:10.3390/cancers13061235 · Cited by 39
Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase
Batuello, C. N., Hauck, P. M., Gendron, J. M., Lehman, J. A., & Mayo, L. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416656112 · Cited by 38
Cukras, S., Morffy, N., Ohn, T., & Kee, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101844 · Cited by 47
Liu, C., Nie, D., Li, J., Du, X., Lu, Y., Li, Y., Zhou, J., Jin, Y., & Pan, J. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1733 · Cited by 36
Tak, I.-U.-R., Ali, F., Dar, J. S., Magray, A. R., Ganai, B. A., & Chishti, M. Z. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00001-1 · Cited by 44
FBXL5-mediated degradation of single-stranded DNA-binding protein hSSB1 controls DNA damage response
Chen, Z., Liu, B., Tang, N., Xu, Y., Ye, X., Li, Z., Niu, X., Shen, S.-P., Lu, S., & Xu, L. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku876 · Cited by 35
Mitochondrial ClpP activity is required for cisplatin resistance in human cells.
Zhang, Y., & Maurizi, M. R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.005 · Cited by 35
The ubiquitin-proteasome system regulates focal adhesions at the leading edge of migrating cells
Teckchandani, A. M., & Cooper, J. A. (2016) · eLife · doi:10.7554/elife.17440 · Cited by 34
TRAF6 neddylation drives inflammatory arthritis by increasing NF-κB activation
Liu, K., Chen, K., Zhang, Q., Zhang, L., Yan, Y., Guo, C., Qi, J., Yang, K., Wang, F., Huang, P., et al. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0175-8 · Cited by 35
Dybas, J. M., O’Leary, C. E., Ding, H., Spruce, L. A., Seeholzer, S. H., & Oliver, P. M. (2019) · Nature Immunology · doi:10.1038/s41590-019-0381-6 · Cited by 37
FAT10: Function and Relationship with Cancer
Xiang, S., Shao, X., Cao, J., Yang, B., He, Q., & Ying, M. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666191113130312 · Cited by 35
Cul3‐Klhl18 ubiquitin ligase modulates rod transducin translocation during light‐dark adaptation
Chaya, T., Tsutsumi, R., Varner, L. R., Maeda, Y., Yoshida, S., & Furukawa, T. (2019) · The EMBO Journal · doi:10.15252/embj.2018101409 · Cited by 36
Le‐Trilling, V. T. K., Becker, T., Nachshon, A., Stern‐Ginossar, N., Schöler, L., Voigt, S., Hengel, H., & Trilling, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.070 · Cited by 35
Neddylation is critical to cortical development by regulating Wnt/β-catenin signaling
Zhang, L., Jing, H., Bailin, P. L., Chen, W., Luo, B., Zhang, H., Dong, Z., Li, L., Su, H., Xiong, W., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005395117 · Cited by 37
Association Between Neddylation and Immune Response
Zhu, J., Chu, F., Zhang, M., Sun, W., & Zhou, F. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.890121 · Cited by 37
Sun, Y., Baechler, S. A., Zhang, X., Kumar, S., Factor, V. M., Arakawa, Y., Chau, C. H., Okamoto, K., Parikh, A. Y., Walker, R. L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39374-9 · Cited by 37
Rico-Bautista, E., Zhu, W., Kitada, S., Ganapathy, S., Lau, E. K., Krajewski, S., Ramirez, J., Bush, J., Yuan, Z.-M., & Wolf, D. A. (2013) · Oncotarget · doi:10.18632/oncotarget.1130 · Cited by 35
Tan, M., Li, Y., Yang, R., Xi, N., & Sun, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027726 · Cited by 37
Wei, W., Guo, H., Liu, X., Zhang, H., Qian, L., Luo, K., Markham, R. B., & Yu, X. (2013) · Journal of Virology · doi:10.1128/jvi.02568-13 · Cited by 39
Szuber, N., Orazi, A., & Tefferi, A. (2024) · American Journal of Hematology · doi:10.1002/ajh.27321 · Cited by 43
Rufini, A., Cavallo, F., Condò, I., Fortuni, S., Martino, G. D., Incani, O., Venere, A. D., Benini, M., Massaro, D. S., Arcuri, G., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.011 · Cited by 41
Nedd8 modification of Cullin-5 regulates lipopolysaccharide-induced acute lung injury
Zhu, Z., Sun, L., Hao, R., Jiang, H., Qian, F., & Ye, R. D. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00410.2016 · Cited by 35
A Destiny for Degradation: Interplay between Cullin-RING E3 Ligases and Autophagy
Lu, G. X., Wang, L., Zhou, J., Liu, W., & Shen, H. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.01.005 · Cited by 35
Krshnan, L., Siu, W. S., van de Weijer, M. L., Hayward, D., Navarro‐Guerrero, E., Grüneberg, U., & Carvalho, P. (2022) · eLife · doi:10.7554/elife.81573 · Cited by 36
The tumour-promoting role of protein homeostasis: Implications for cancer immunotherapy
Liang, R., Tan, H., Jin, H., Wang, J., Tang, Z., & Lu, X. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216354 · Cited by 35
Walker, D. M., Mahfooz, N. S., Kemme, K. A., Patel, V. C., Spangler, M., & Drew, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067047 · Cited by 37
Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme
Zhong, H., Liu, L., Chan, D. S., Wang, H., Chan, P. W. H., Ma, D., & Leung, C. (2014) · Biochimie · doi:10.1016/j.biochi.2014.03.005 · Cited by 34
Tan, M. M. L., Li, H., & Sun, Y. (2013) · Oncogene · doi:10.1038/onc.2013.473 · Cited by 34
Li, J., Ma, W., Li, H., Hou, N., Wang, X., Kim, I., Li, F., & Su, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664375 · Cited by 34
SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses
Mathewson, N. D., Fujiwara, H., Wu, S.-R. J., Toubai, T., Oravecz-Wilson, K. I., Sun, Y., Rossi, C., Zajac, C. K., Sun, Y., & Reddy, P. R. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.014 · Cited by 34
Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
Bulatov, E., Zagidullin, A. A., Valiullina, A., Sayarova, R., & Rizvanov, A. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00450 · Cited by 35
Liu, D., Che, X., & Wu, G. (2024) · Biomarker Research · doi:10.1186/s40364-023-00545-x · Cited by 38
Proteasome lid bridges mitochondrial stress with Cdc53/Cullin1 NEDDylation status
Bramasole, L., Sinha, A., Gurevich, S. Z., Radzinski, M., Klein, Y., Panat, N. A., Gefen, E., Rinaldi, T., Jimenez‐Morales, D., Johnson, J. R., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.11.010 · Cited by 33
The SCFSkp2 ubiquitin ligase complex modulates TRAIL-R2-induced apoptosis by regulating FLIP(L)
Roberts, J. Z., Holohan, C., Sessler, T., Fox, J. P., Crawford, N., Riley, J. S., Khawaja, H. A., Majkut, J., Evergren, E., Humphreys, L. M., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0539-7 · Cited by 34
Neddylation: A Versatile Pathway Takes on Chronic Liver Diseases
Yao, J., Liang, X. Y., Liu, Y., & Zheng, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.586881 · Cited by 34
Spastin recovery in hereditary spastic paraplegia by preventing neddylation-dependent degradation
Sardina, F., Pisciottani, A., Ferrara, M., Valente, D., Casella, M., Crescenzi, M., Peschiaroli, A., Casali, C., Soddu, S., Grierson, A. J., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.202000799 · Cited by 42
Ji, M., Zhao, Z., Li, Y., Xu, P., Shi, J., Li, Z., Wang, K., Huang, X., Ji, J., Liu, W., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04040-9 · Cited by 33
Yuan, T., Zhou, T., Qian, M., Du, J., Liu, Y., Wang, J., Li, Y., Fan, G., Yan, F., Dai, X., et al. (2022) · Hepatology · doi:10.1002/hep.32621 · Cited by 39
Xu, C., Zhou, H., Jin, Y., Sahay, K., Robicsek, A., Liu, Y., Dong, K., Zhou, J., Barrett, A., Su, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35525-6 · Cited by 35
Serrano, M. (2010) · Nature · doi:10.1038/464363a · Cited by 38
Thomas, J. C., Matak‐Vinković, D., Molle, I. V., & Ciulli, A. (2013) · Biochemistry · doi:10.1021/bi400758h · Cited by 36
da Silva, S. D., Paiva, S.-L., Lukkarila, J. L., & Gunning, P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301420b · Cited by 29
Itch promotes the neddylation of JunB and regulates JunB-dependent transcription
Bailin, P. L., Zhu, H., Liu, Y., He, F., Xie, P., & Zhang, L. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.05.016 · Cited by 33
Termathe, M., & Leidel, S. A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky312 · Cited by 33
Filippova, N., Yang, X., An, Z., Nabors, B., & Pereboeva, L. (2018) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000543 · Cited by 35
Zhang, W., Liang, Y., Li, L., Wang, X., Yan, Z., Dong, C., Zeng, M., Zhong, Q., Liu, X., Yu, J., et al. (2018) · Cell Proliferation · doi:10.1111/cpr.12536 · Cited by 34
Self-citationYu, S., Xie, L., Liu, Z., Li, C., & Liang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7283639 · Cited by 35
Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics
Steger, M., Nishiguchi, G., Wu, Q., Schwalb, B., Shashikadze, B., McGowan, K., Actis, M., Aggarwal, A., Shi, Z., Price, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62829-0 · Cited by 32
“For hits that showed signi fi cant protein downregulation at both time points, we con fi rmed cullin-RING E3 ligase (CRL)-dependency by co-treating cells with the respective MGD and the NEDD8-activating enzyme inhibitor MLN4924 19 .”
InfluentialBanerjee, S., Zagórska, A., Deak, M., Campbell, D. G., Prescott, A. R., & Alessi, D. R. (2014) · Biochemical Journal · doi:10.1042/bj20140408 · Cited by 32
“This effect of calyculin A was blocked by treating cells with the specific MLN4924 inhibitor that inactivates SCF E3 ubiquitin ligase complexes by suppressing NEDDylation of Cul-1 [26] (Figure 3B).”
Alwahsh, M., Farhat, J., Talhouni, S., Hamadneh, L., & Hergenröder, R. (2023) · EXCLI journal · doi:10.17179/excli2022-5653 · Cited by 47
MLN4924 therapy as a novel approach in cancer treatment modalities
Oladghaffari, M., Islamian, J. P., Baradaran, B., & Monfared, A. S. (2015) · Journal of Chemotherapy · doi:10.1179/1973947815y.0000000066 · Cited by 32
Targeting the Ubiquitin+Proteasome System in Solid Tumors
Driscoll, J. J., & Woodle, E. S. (2012) · Seminars in Hematology · doi:10.1053/j.seminhematol.2012.04.002 · Cited by 32
Ramachandran, S. S., Osterhaus, S. R., Parekh, K. R., Jacobi, A. M., Behlke, M. A., & McCray, P. B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754283 · Cited by 34
FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration
Fung, E., Richter, C., Yang, H., Schäffer, I., Fischer, R., Kessler, B. M., Bassermann, F. C., & D’Angiolella, V. (2018) · EMBO Reports · doi:10.15252/embr.201744799 · Cited by 35
Hou, L., Zhao, J., Gao, S., Ji, T., Song, T., Li, Y., Wang, J., Geng, C., Long, M., Chen, J., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau7130 · Cited by 28
FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells
Saffie, R., Zhou, N., Rolland, D. C. M., Önder, Ö., Basrur, V., Campbell, S. L., Wellen, K. E., Elenitoba‐Johnson, K. S. J., Capell, B. C., & Busino, L. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2247 · Cited by 33
Discovery and optimization of pyrazolopyrimidine sulfamates as ATG7 inhibitors
Huang, S., Adhikari, S., Brownell, J. E., Calderwood, E. F., Chouitar, J., D’Amore, N. R., England, D. B., Foley, K., Harrison, S. J., Leroy, P. J., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115681 · Cited by 33
Self-citationArena3Dweb: interactive 3D visualization of multilayered networks
Karatzas, E., Baltoumas, F. A., Panayiotou, N. A., Schneider, R., & Pavlopoulos, G. A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab278 · Cited by 34
Lin, H., Yan, Y. C., Luo, Y., So, W. Y., Wei, X., Zhang, X., Yang, X., Zhang, J., Su, Y., Yang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22941-3 · Cited by 32
Self-citationCell cycle regulation by complex nanomachines
Koliopoulos, M. G., & Alfieri, C. (2021) · FEBS Journal · doi:10.1111/febs.16082 · Cited by 33
Zarnegar‐Lumley, S., Caldwell, K. J., & Rubnitz, J. E. (2022) · Leukemia · doi:10.1038/s41375-022-01619-9 · Cited by 36
Han, K., Wang, Q., Cao, H., Qiu, G.-H., Cao, J., Li, X., Wang, J., Shen, B., & Zhang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8068 · Cited by 32
Self-citationCvek, B. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00005-5 · Cited by 34
Bulatov, E., Valiullina, A., Sayarova, R., & Rizvanov, A. A. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.08.001 · Cited by 33
Novel Class of Viral Ankyrin Proteins Targeting the Host E3 Ubiquitin Ligase Cullin-2
Odon, V., Georgana, I., Holley, J. A., Morata, J., & de Motes, C. M. (2018) · Journal of Virology · doi:10.1128/jvi.01374-18 · Cited by 32
Salerno, A., Wieske, L. H. E., Diehl, C. J., & Ciulli, A. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c18354 · Cited by 35
Cell competition in tumor evolution and heterogeneity: Merging past and present
Pelham, C. J., Nagane, M., & Madan, E. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.008 · Cited by 37
Wu, Y., Doepner, M., Hojnacki, T., Feng, Z., Katona, B. W., He, X., Ma, J., Cao, Y. H., Busino, L., Zhou, F., et al. (2019) · PubMed · Cited by 33
Cullin RING Ligase 5 (CRL-5): Neddylation Activation and Biological Functions
Zhang, S., & Sun, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_16 · Cited by 32
Metadata
- Authors
- Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., Cullis, C. A., Doucette, A., Garnsey, J. J., Gaulin, J. L., Gershman, R. E., Lublinsky, A. R., McDonald, A., Mizutani, H., Narayanan, U., Olhava, E. J., Peluso, S., Rezaei, M., Sintchak, M. D., Talreja, T., Thomas, M. P., Traore, T., Vyskocil, S., Weatherhead, G. S., Yu, J., Zhang, J., Dick, L. R., Claiborne, C. F., Rolfe, M., Bolen, J. B., & Langston, S. P.
- Affiliations
- Takeda Oncology (United States) (US)
- Corresponding author
- Soucy, Teresa A.
- ORCID
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7239
- Pages
- 732-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2076194625
- Cited by
- 1,990
- References
- 46
- Citations by year
- 2026: 110 · 2025: 120 · 2024: 156 · 2023: 126 · 2022: 137 · 2021: 155 · 2020: 170 · 2019: 149 · 2018: 112 · 2017: 105 · 2016: 108 · 2015: 98 · 2014: 99 · 2013: 100 · 2012: 100
- FWCI
- 32.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- NEDD8-activating enzyme, MLN4924, cullin-RING ubiquitin ligases, ubiquitin-proteasome system, proteasome inhibitors, cancer cell death, tumor xenografts, small molecule inhibitors, antitumour activity
- MeSH terms
- NEDD8 Protein, Animals, Antineoplastic Agents, Cells, Cultured, Cyclopentanes, Enzyme Inhibitors, Female, Humans, Neoplasms, Pyrimidines, Transplantation, Heterologous, Ubiquitins, Ubiquitin-Activating Enzymes, Cullin Proteins, Cell Line, Tumor, Mice, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.